Overview
Bruce Redman is an Oncologist in Ann Arbor, Michigan. Dr. Redman is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma.
His clinical research consists of co-authoring 31 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Regents Of The University Of Michigan
Ajjai Alva is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Alva is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Lymphadenectomy, and Nephrectomy. Dr. Alva is currently accepting new patients.
Regents Of The University Of Michigan
Ulka Vaishampayan is an Oncologist in Northville, Michigan. Dr. Vaishampayan is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is currently accepting new patients.
Henry Ford Health System
Sheela Tejwani is an Oncologist and a Hematologist in Detroit, Michigan. Dr. Tejwani is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Adult Soft Tissue Sarcoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Rhabdomyosarcoma, and Bone Marrow Aspiration. Dr. Tejwani is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Redman isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Renal Cell Carcinoma (RCC)Dr. Redman isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- WT1-Related Wilms Tumor SyndromesDr. Redman isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Adult Soft Tissue SarcomaDr. Redman isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Clear Cell SarcomaDr. Redman isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Redman isAdvanced. Learn about Familial Wilms Tumor 2.
- MelanomaDr. Redman isAdvanced. Learn about Melanoma.
- Posterior Fossa TumorDr. Redman isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Experienced
- Familial Prostate CancerDr. Redman isExperienced. Learn about Familial Prostate Cancer.
- Metastatic Brain TumorDr. Redman isExperienced. Learn about Metastatic Brain Tumor.
- Prostate CancerDr. Redman isExperienced. Learn about Prostate Cancer.